These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38993131)

  • 1. Children with eosinophilic esophagitis non-responsive to combination therapy have distinct esophageal transcriptomic and microbiome profile.
    Hiremath G; Choksi Y; Correa H; Jacobse J; Das SR; Ma S; Goettel JA; Rajagopala SV
    Allergy; 2024 Oct; 79(10):2798-2811. PubMed ID: 38993131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies.
    Laserna-Mendieta EJ; FitzGerald JA; Arias-Gonzalez L; Ollala JM; Bernardo D; Claesson MJ; Lucendo AJ
    Sci Rep; 2021 Mar; 11(1):7113. PubMed ID: 33782490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
    Wen T; Dellon ES; Moawad FJ; Furuta GT; Aceves SS; Rothenberg ME
    J Allergy Clin Immunol; 2015 Jan; 135(1):187-97. PubMed ID: 25441638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlapping Transcriptional Profile in Proton Pump Inhibitor Responsive and Nonresponsive Eosinophilic Esophagitis.
    Hamilton MJ; Muftah M; Goldin AH; Lo WK; Hsu Blatman KS; Chan WW; Srivastava A
    Clin Transl Gastroenterol; 2022 Nov; 13(11):e00540. PubMed ID: 36201660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and gene expression analysis of initial biopsies from patients with eosinophilic esophagitis refractory to therapy.
    Siddique AS; Corney DC; Mangray S; Lombardo KA; Chen S; Marwaha AS; Resnick MB; Herzlinger M; Matoso A
    Hum Pathol; 2017 Oct; 68():79-86. PubMed ID: 28882697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
    Dohil R; Newbury RO; Aceves S
    Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
    Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP
    J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.
    Molina-Infante J; Prados-Manzano R; Gonzalez-Cordero PL
    Expert Rev Clin Immunol; 2016 Sep; 12(9):945-52. PubMed ID: 27097787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of eosinophilic esophagitis by gene expression profiling.
    Wen T; Stucke EM; Grotjan TM; Kemme KA; Abonia JP; Putnam PE; Franciosi JP; Garza JM; Kaul A; King EC; Collins MH; Kushner JP; Rothenberg ME
    Gastroenterology; 2013 Dec; 145(6):1289-99. PubMed ID: 23978633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration.
    Fujiwara Y; Sugawa T; Tanaka F; Tatsuwaki H; Okuyama M; Hayakawa T; Yamamori K; Wada R; Ohtani K; Uno H; Tanigawa T; Watanabe Y; Tominaga K; Watanabe T; Takaishi O; Saeki Y; Nebiki H; Oshitani N; Sato H; Arakawa T
    Intern Med; 2012; 51(23):3235-9. PubMed ID: 23207117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
    Irastorza LE; Hopson P; Nabar S; Deb C; Smadi Y
    J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):267-271. PubMed ID: 34321427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
    Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
    Eur J Pediatr; 2024 Aug; 183(8):3567-3578. PubMed ID: 38819501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-Microbiota Interactions in the Esophagus During Homeostasis and Allergic Inflammation.
    Brusilovsky M; Bao R; Rochman M; Kemter AM; Nagler CR; Rothenberg ME
    Gastroenterology; 2022 Feb; 162(2):521-534.e8. PubMed ID: 34627858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
    Ishimura N; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.